Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Sharmila Dissanaike currently holds 53,960 shares of HERON THERAPEUTICS, INC. /DE/ (HRTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Sharmila Dissanaike has been a net neutral trader of HRTX stock. They have purchased $0 and sold $0 worth of shares.
Sharmila Dissanaike's most recent insider trade was on Jan 30, 2026, when they sold 53,960 shares at $0.00 per share.
Sharmila Dissanaike serves as Executive at HERON THERAPEUTICS, INC. /DE/ (HRTX). They have executed 5 insider transactions totaling $0 over their tenure at the company.
Sharmila Dissanaike holds the position of Executive at HERON THERAPEUTICS, INC. /DE/, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 5 years and currently hold a stake valued at $0.
Sharmila Dissanaike has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Sharmila Dissanaike was on Jan 30, 2026, when they purchased $0 worth of HRTX shares. This transaction involved 53,960 shares at N/A per share.
Sharmila Dissanaike currently owns 53,960 shares of HERON THERAPEUTICS, INC. /DE/ (HRTX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Sharmila Dissanaike's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Sharmila Dissanaike has 5 Form 4 filings on record as an insider at HERON THERAPEUTICS, INC. /DE/.
Set alerts for Sharmila Dissanaike and 40,000+ other insiders.